Advanced Therapies Congress 2025 London United Kingdom Del 18/03/2025 to 19/03/2025 Healthcare Access to innovation International
GENESIS Biomed sponsors the 3rd Conference on Healthcare Entrepreneurship at the Gregorio... 28/11/2024 Healthcare Access to innovation The conference highlighted the importance of planning funding to ensure the survival of spin-offs and the development of... Partners - GENESIS Biomed
BCN HEALTH publishes a study evaluating the relationship between kidney failure, heart dis... 25/11/2024 Healthcare Access to innovation BCN HEALTH has published the study ‘Relationship between a diagnosis of kidney failure and heart diseases in patients... Partners - BCN Health
LeishGen: Advanced Genomic Platforms for Drug Resistance Biomarkers in Leishmania infantum 20/11/2024 Healthcare Access to innovation Antibiotic resistance LeishGenApp and LeishGenR are Nano1Health’s cutting-edge solutions for detecting drug resistance biomarkers in... Partners - Nano1Health SL
The data revolution and AI in the Health sector 14/11/2024 Healthcare Access to innovation The data and artificial intelligence revolution is driving deep changes in medical research. Partners - GENESIS Biomed
The Fight Against Pneumonia and Antibiotic Resistance: Vaxdyn and the K-Vax Vaccine Candid... 11/11/2024 Healthcare Access to innovation Innovative drugs On the occasion of World Pneumonia Day, we interviewed Juanjo Infante, CEO of Vaxdyn, a biotech company developing the K... Partners
Access to Innovative Therapies in Spain: Challenges and Opportunities 07/11/2024 Healthcare Access to innovation Innovative drugs Advanced therapies International In this article, Chus Castillo, Partner Consulting Iberia at Alira Health, and Ion Arocena, General Manager at AseBio... Partners
SunLabs and MERLIN Properties Sign Exclusive Commercialization Agreement Over 5,000 Square... 08/10/2024 Healthcare Access to innovation The new SunLabs facility will be a cutting-edge life sciences research and development hub. Other/sector
INBRAIN Neuroelectronics Raises $50M Series B to Advance Graphene-Based Brain-Computer In... 29/10/2024 Healthcare Access to innovation Innovative drugs VC funding led by imec.xpand, with significant participation from the EIC Fund (venture arm of the European Innovation... Partners - Asabys Partners
Menarini and the Germans Trias i Pujol Research Institute sign an agreement to promote res... 29/10/2024 Healthcare Access to innovation The organisations are collaborating on two studies in the field of severe Legionella infections and antibiotic... Partners - Germans Trias i Pujol Research Institute (IGTP)
